Jill Wechsler, ACT's Washington Correspondent

Jill Wechsler is ACT's Washington Correspondent


Congressional Probe of Alzheimer’s Drug Hits FDA Interactions with Industry

January 09, 2023

House report on Aduhelm approval calls for FDA to clarify its role in advising sponsors on drug testing and submissions.

Massive Government Spending Bill Tackles Key FDA and Research Issues

December 22, 2022

The Consolidated Appropriations Act for 2023 includes dozens of measures involving drug development and regulation.

Major FDA Reform Unlikely in Closely Divided Congress

November 10, 2022

Following closely contested election, approval of FDA bills most likely tabled until new year.

Pressure Mounts for FDA to Reform Accelerated Approval Program

October 26, 2022

Potential drug removal spotlights latest debate over the expedited pathway.